TXN and breast adenocarcinoma: Here, Femel et al. therapeutically vaccinated the transgenic MMTV-PyMT mice model of metastatic mammary adenocarcinoma with a construct consisting of the ED-A fragment (<90 aa) conjugated to bacterial thioredoxin (TRX).